We have updated our Aphria research pitch, including the impact of COVID-19 on our forecast. We have also updated our recommendation, price target, and cannabis price/demand curves. We have also made our Aphria financial model available.
You must be an Institutional Equity Research Subscriber to view the rest of this pageYou may also like
We have updated our full marketing presentation on Aphria. This easy to follow 18-slide pitch updates the expected per store sales change for Ontario, […]
Aphria released further details on the Latin America operations. The details on the release did not portray businesses worth anything close to the […]
Updated on February 7th. Written by Robin Manson-Hing with Contributions from Saif Shah. We have received exclusive photos on Aphria’s phase 3 […]
With Aphria (APH-TSX) closing at $8.53 on Friday, the stock price is now roughly 5% above our fundamental target of $8.13. We began […]